1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Key Pharma News 16 NOVEMBER 2015

Key Pharma News 16 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 22 pages

Industry Trend Analysis - TPP Agreement Will Face National Implementation Battles
Industry Trend Analysis - Sanofi Targets Oncology For Growth
Industry Trend Analysis - AbbVie Portfolio Shift Will Be Gradual
Industry Trend Analysis - J&J Poised For Hepatitis Leadership
Industry Trend Analysis - BioMab Divestment Will Aid Cipla's Biosimilar Ambitions
Industry Brief - BMS To Acquire Cardioxyl Pharmaceuticals
Industry Trend Analysis - Mylan On Course To Achieve USD3bn Revenues In Q415
Industry Brief - Perrigo's Legal Challenges Against Mylan Denied
Industry Brief - Shire To Acquire Dyax
Industry Brief - AstraZeneca To Acquire ZS Pharma
Industry Brief - Novo Nordisk Invests In Hillerod Facility
Industry Brief - Proposed Mylan Acquisition of Perrigo Clears FTC
Industry Brief - BI To Invest EUR11bn In Five-Year R&D Programme
Industry Trend Analysis - Deep Pipeline Shifts Driving Industry-Wide Manufacturing Network Changes
Industry Trend Analysis - Cotellic/Zelboraf Potential Lies Beyond Melanoma
Industry Trend Analysis - Gilead To Maintain HIV Position Through Proactive Defence Strategy
Industry Trend Analysis - FTC's Outlook Impedes FDA Biosimilar Naming Plans
Industry Trend Analysis - Compulsory Licence Request Pressurises Government To Reform Patent Laws
Industry Trend Analysis - Abuse-Deterrent Formulations Will Not Curb Opioid Abuse Alone
Industry Trend Analysis - Early Companion Diagnostic Implementation To Rise
Industry Trend Analysis - NASH Burden Spurring Innovation
Industry Trend Analysis - Encenicline Back On Course For 2016 NDA

Table Of Contents

Key Pharma News 16 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.